VERTEX PHARMACEUTICALS INC / MA Other Current Assets
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Other Current Assets of $110.90 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-02-13
- 2025-12-31: Other Assets, Current $110.90M.
- 2024-12-31: Other Assets, Current $76.40M.
- 2023-12-31: Other Assets, Current $84.30M.
- 2022-12-31: Other Assets, Current $74.40M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $110.90M 10-K · filed 2026-02-13 | |
| 2024-12-31 | $76.40M 10-K · filed 2026-02-13 | |
| 2023-12-31 | $84.30M 10-K · filed 2025-02-13 | |
| 2022-12-31 | $74.40M 10-K · filed 2024-02-15 | |
| 2021-12-31 | $59.20M 10-K · filed 2023-02-10 | $187.20M 10-K · filed 2022-02-09 |
| 2020-12-31 | $79.70M 10-K · filed 2022-02-09 | |
| 2018-12-31 | $61.59M 10-K · filed 2019-02-13 | |
| 2017-12-31 | $75.74M 10-K · filed 2019-02-13 | $74.25M 10-K · filed 2018-02-15 |
| 2016-12-31 | $34.40M 10-K · filed 2018-02-15 | $16.78M 10-K · filed 2017-02-23 |
| 2015-12-31 | $12.84M 10-K · filed 2017-02-23 | $12.06M 10-K · filed 2016-02-16 |
| 2014-12-31 | $7.00M 10-K · filed 2016-02-16 | |
| 2013-12-31 | $524.00K 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |